Foxp3-targeting antisense oligonucleotides (AUM LifeTech/Children’s Hospital of Philadelphia/Perelman School of Medicine)

N/A

Report date: 2025/03/20 15:16:27
NME

Base Information

Drug NameFoxp3-targeting antisense oligonucleotides (AUM LifeTech/Children’s Hospital of Philadelphia/Perelman School of Medicine)
Drug Alias NameFoxp3 gene silencing FANA antisense oligonucleotides therapy (AUM LifeTech/Children's Hosp Philadelphia/Perelman School of Medicine)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionForkhead box protein P3 expression inhibitors
TargetsForkhead box protein P3
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAUM LifeTech
China Registration ClassN/A

Develop Information

Active CompaniesChildrens Hospital of PhiladelphiaAUM LifeTechUniversity Of Pennsylvania Perelman School Of Medicine
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A